PRO DEX INC (PDEX) Stock Price, Financials & Summary

Price chart

Oct 7Oct 12Oct 15Oct 20Oct 23Oct 28Nov 2Nov 5

Key dataNov 5, 2026

Open$63.43

From 52W high−16.63%

Volume36791.00

Market cap$195.84M

P/E (TTM)16.4x

P/S (TTM)2.5x

Div yield—

Key dataNov 5, 2026

Open

$63.43

From 52W high

−16.63%

Volume

36791.00

Market cap

$195.84M

ValuationView details →

P/E (Fwd)

19.2x

EV/EBITDA

11.8x

P/E (TTM)

16.4x

RSI (14)

52.5

MomentumView details →

1D Return

−3.53%

YTD Return

+64.50%

SummaryUpdated Sep 1, 2026

Pro-Dex, Inc. (NASDAQ:PDEX) is a specialized medical device manufacturer founded in 1978 and headquartered in Irvine, California. The company went public in 1986 and has established itself as a niche player in the powered surgical instruments market. Pro-Dex primarily serves as an original equipment manufacturer (OEM) partner to larger medical device companies, designing and manufacturing precision surgical tools used in orthopedic, thoracic, and craniomaxillofacial procedures. The company has built its reputation on producing high-quality, autoclavable surgical instruments that meet the stringent requirements of modern operating rooms.

Ask drillr about PRO DEX INC →

ValuationView details →

P/E (Fwd)

19.2x

P/E (TTM)

16.4x

EV/EBITDA

11.8x

EV/Sales

2.5x

P/S (TTM)

2.5x

P/B (TTM)

4.0x

ProfitabilityView details →

Gross Margin

32.45%

Net Margin

15.12%

EBITDA Margin

21.54%

ROE (TTM)

24.38%

ROA (TTM)

15.71%

Asset Turnover

1.05x

GrowthView details →

Revenue YoY

+13.31%

EPS YoY

+9.04%

FCF YoY

+598.34%

Revenue CAGR 3Y

+18.94%

EPS CAGR 3Y

+28.89%

EBITDA YoY

+0.32%

MomentumView details →

1D Return

−3.53%

YTD Return

+64.50%

1Y Return

+94.23%

RSI (14)

52.5

vs 50D SMA

−1.76%

vs 200D SMA

+11.15%

Capital & dividendView details →

Debt/Equity

0.38x

Current Ratio

4.19x

Quick Ratio

2.49x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$0.92

EPS Surprise

36.90%

Beats (12Q)

9/12

Next Q EPS Est

$0.72

Avg Surprise (4Q)

41.92%

Rev Surprise

0.49%

Financials snapshotView financials →

Revenue (TTM)

79.58M

Net Income (TTM)

12.03M

Op. CF (TTM)

11.42M

Next earningsFeb 4, 2027 →

Latest newsMore news →

PRO DEX INC reported first-quarter fiscal 2027 revenue of $20.56 million, net income of $3.048 million and diluted earnings per share of $0.92.7d ago

PRO DEX Inc, as lessee, amended its Standard Industrial/Commercial Multi-Tenant Lease with Irvine Business Properties, extending the lease term to September 30, 2030 and setting a new base rent schedule.48d ago

Similar companies

Utah Medical Products, Inc.UTMD OraSure Technologies, Inc.OSUR Anbio Biotechnology Class A Ordinary SharesNNNN KORU Medical Systems, Inc.KRMD Sanara MedTech Inc.SMTI Kelfred Holdings Limited01134.HK Find similar companies →

Latest newsMore news →

PRO DEX INC reported first-quarter fiscal 2027 revenue of $20.56 million, net income of $3.048 million and diluted earnings per share of $0.92.7d ago PRO DEX Inc, as lessee, amended its Standard Industrial/Commercial Multi-Tenant Lease with Irvine Business Properties, extending the lease term to September 30, 2030 and setting a new base rent schedule.48d ago